E-ISSN 2534-9821
 

Original Research 


Dobesilate: A potential therapy for long-covid?

Pedro Cuevas, Antonio Manquillo, Javier Angulo, Guillermo Giménez-Gallego.

Abstract
On the basis of the involvement of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) in inflammation and vascular changes in COVID-19, we hypothesized that Dobesilate, a demonstrated anti-FGF and anti-VEGF drug might be beneficial for treating COVID-19 patients. We conducted a study and recruited 13 patients with long-COVID syndrome from one center. Dobesilate (Doxium® 1g, twice a day for 15 days) shows clinical efficacy by improving symptoms in these patients.

Key words: SARS-CoV-2, COVID-19, Long-COVID, Dobesilate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Pedro Cuevas
Articles by Antonio Manquillo
Articles by Javier Angulo
Articles by Guillermo Giménez-Gallego
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep. 2021; 5(14): 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid


Web Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. Dobesilate: A potential therapy for long-covid?. http://www.mdpub.net/?mno=132256 [Access: December 31, 2021]. doi:10.5455/IJMRCR.dobesilate-long-covid


AMA (American Medical Association) Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep. 2021; 5(14): 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid



Vancouver/ICMJE Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep. (2021), [cited December 31, 2021]; 5(14): 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid



Harvard Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego (2021) Dobesilate: A potential therapy for long-covid?. Int J Med Rev Case Rep, 5 (14), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid



Turabian Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. 2021. Dobesilate: A potential therapy for long-covid?. International Journal of Medical Reviews and Case Reports, 5 (14), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid



Chicago Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. "Dobesilate: A potential therapy for long-covid?." International Journal of Medical Reviews and Case Reports 5 (2021), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid



MLA (The Modern Language Association) Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego. "Dobesilate: A potential therapy for long-covid?." International Journal of Medical Reviews and Case Reports 5.14 (2021), 5-10. Print. doi:10.5455/IJMRCR.dobesilate-long-covid



APA (American Psychological Association) Style

Pedro Cuevas| Antonio Manquillo| Javier Angulo| Guillermo Giménez-Gallego (2021) Dobesilate: A potential therapy for long-covid?. International Journal of Medical Reviews and Case Reports, 5 (14), 5-10. doi:10.5455/IJMRCR.dobesilate-long-covid